|
Market Cap (4-Jul) $72,989,640 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (19-Jun) 12,988,365 (0.64%) (278th) |
|
52w High $0.071 |
52w Low $0.026 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 31 January 2022, 9:08. The announcement is marked as price sensitive, and is 24 page(s) in length and 1.37MB in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 0.447% short sold according to ASIC data. It was ranked the 305th most shorted stock on the ASX. It is now ranked as the 278th most shorted stock on the ASX with 0.641% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| Appendix 4C & Quarterly Activities Report | 31 January 2022, 9:08 |
| ImpediMed Quarterly Results and Investor Conference Call | 27 January 2022, 15:07 |
| Change of Director's Interest Notice - Ms Judith Downes | 6 January 2022, 19:40 |
| Change of Director's Interest Notice - Dr Robert Graham | 6 January 2022, 19:39 |
You must be logged in to post a reply.
ImpediMed 